Linco-Spectin® Sterile Solution is an injectable antibiotic containing lincomycin and spectinomycin. Lincomycin is an antibiotic produced by Streptomyces lincolnensis and is chemically distinct from all other clinically available antibiotics.
 
It is readily soluble in water. It is effective in vitro against most of the common gram-positive pathogens. Spectinomycin is an antibiotic produced by Streptomyces flavopersicus. Spectinomycin free base is weakly basic and readily soluble in water. It has in vivo and in vitro activity against many gram-positive and gram-negative organisms but, like lincomycin, is inactive against yeasts, molds, and viruses.
 
Poultry / Pigeon
 
Antibacterial or antimycoplasmal therapy against sensitive organisms. For the treatment and prevention of Chronic Respiratory Disease (CRD) associated with mycoplasma and coliform infections of growing poultry susceptible to the action of the antibiotic combination.
 
Indications for use, specifying the target species
 
Linco-Spectin Sterile Solution is indicated for the treatment of infections caused by organisms sensitive to the action of lincomycin and / or spectinomycin including:
 
Actinobacillus spp.
Pasteurella spp.
Serpulina hyodysenteriae
Escherichia coli Salmonella spp.
Campylobacter spp.
Bacteroides spp.
Clostridium spp.
Fusobacterium spp.
Actinomyces spp.
Streptococcus spp.
Mycoplasma spp.
 
Contraindications
 
Do not use in animals previously found to be hypersensitive to either active ingredient. Do not administer to rabbits, hamsters, guinea pigs, chinchillas, horses or ruminants as this could result in severe gastro-intestinal disturbance.
 
Special warnings for each target species
 
None.
 
Special precautions for use 
 
Special precautions for use in animals
 
None
 
Special Precautions to be taken by the Person Administering the Product to Animals
 
 None.
 
Adverse reactions (frequency and seriousness)
 
The use of this product may cause occasional local discomfort upon injection. At higher levels than recommended in pigs, the product may give rise to transient diarrhoea or loose stools. Such an effect may rarely occur in some pigs at the recommended dose, as well as occasional loss of appetite.
 
Use during pregnancy, lactation or lay
 
This product may be used during pregnancy and lactation. Do not use in animals producing milk for human consumption.
 
Interaction with other medicinal products and other forms of interaction
 
None.
 
Amounts to be administered and administration route
 
By intramuscular injection.
 
Pigs: 15mg combined activity per kg bwt (1 ml/10 kg bwt) intramuscularly, to be repeated daily for 3 days according to clinical response.
 
Non-ruminating calves: 15 mg combined activity per kg bwt (1ml/10kg bwt) intramuscularly twice daily for the first day followed by once daily for 2-4 days according to clinical response.
 
Overdose (symptoms, emergency procedures, antidotes), if necessary
 
Not applicable.
 
Withdrawal period(s)
 
Pigs: Meat and offal: 14 days.
 
Non-ruminating calves: Meat and offal: 21 days